Emend
Active Ingredient(s): AprepitantFDA Approved: * March 27, 2003
Pharm Company: * MERCK
Category: Nausea & Vomiting
Aprepitant, sold under the brand name Emend among others, is a medication used to prevent chemotherapy-induced nausea and vomiting (CINV) and to prevent postoperative nausea and vomiting.[1] It may be used together with ondansetron and dexamethasone.[1] It is taken by mouth.[1] Common side effects include tiredness, loss of appetite, diarrhea, abdominal pain, hiccups, itchiness, pneumonia, and blood pressure changes.[1] Other sev... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.1 Discussion
Dosage List
Emend 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 0006-3061
Labeler:
Merck Sharp & Dohme Corp.
Emend 115 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 0006-3884
Labeler:
Merck Sharp & Dohme Corp.
Emend 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 0006-3941
Labeler:
Merck Sharp & Dohme Corp.
Popular Topics
Are people taking Emend who do not have cancer?
Hi, I have severe gastroparesis for 5 years now. I’ve been through tubes, pics, ports, pyloroplasty and Botox. I a...
1 REPLY